Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy AIkido Pharma stock | $1.07
Learn how to easily invest in AIkido Pharma stock.
AIkido Pharma Inc is a biotechnology business based in the US. AIkido Pharma shares (AIKI) are listed on the NASDAQ and all prices are listed in US Dollars. AIkido Pharma employs 4 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in AIkido Pharma
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AIKI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
AIkido Pharma stock price (NASDAQ: AIKI)Use our graph to track the performance of AIKI stocks over time.
AIkido Pharma shares at a glance
|Latest market close||$1.07|
|52-week range||$0.47 - $2.55|
|50-day moving average||$0.94|
|200-day moving average||$1.13|
|Wall St. target price||$19.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.97|
Buy AIkido Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy AIkido Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AIkido Pharma price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||11.46%|
|3 months (2021-04-30)||3.88%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
AIkido Pharma financials
|Gross profit TTM||$9,000|
|Return on assets TTM||-6.39%|
|Return on equity TTM||-12.71%|
|Market capitalisation||$78.4 million|
TTM: trailing 12 months
Shorting AIkido Pharma shares
There are currently 715,826 AIkido Pharma shares held short by investors – that's known as AIkido Pharma's "short interest". This figure is 2.2% up from 700,536 last month.
There are a few different ways that this level of interest in shorting AIkido Pharma shares can be evaluated.
AIkido Pharma's "short interest ratio" (SIR)
AIkido Pharma's "short interest ratio" (SIR) is the quantity of AIkido Pharma shares currently shorted divided by the average quantity of AIkido Pharma shares traded daily (recently around 2.3 million). AIkido Pharma's SIR currently stands at 0.31. In other words for every 100,000 AIkido Pharma shares traded daily on the market, roughly 310 shares are currently held short.
However AIkido Pharma's short interest can also be evaluated against the total number of AIkido Pharma shares, or, against the total number of tradable AIkido Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AIkido Pharma's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 AIkido Pharma shares in existence, roughly 10 shares are currently held short) or 0.0087% of the tradable shares (for every 100,000 tradable AIkido Pharma shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AIkido Pharma.
Find out more about how you can short AIkido Pharma stock.
AIkido Pharma share dividends
We're not expecting AIkido Pharma to pay a dividend over the next 12 months.
Have AIkido Pharma's shares ever split?
AIkido Pharma's shares were split on a 1113:1000 basis on 27 October 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1113 shares. This wouldn't directly have changed the overall worth of your AIkido Pharma shares – just the quantity. However, indirectly, the new 10.2% lower share price could have impacted the market appetite for AIkido Pharma shares which in turn could have impacted AIkido Pharma's share price.
AIkido Pharma share price volatility
Over the last 12 months, AIkido Pharma's shares have ranged in value from as little as $0.4656 up to $2.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AIkido Pharma's is 1.562. This would suggest that AIkido Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
AIkido Pharma overview
AIkido Pharma Inc. , a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc.
Stocks similar to AIkido Pharma
AIkido Pharma in the news
Notice of Allowance Issued for Central Nervous System Peptide Technology
Notice of Allowance Issued for Central Nervous System Peptide Technology
AIkido Pharma announces Notice of Allowance for CNS peptide technology
Frequently asked questionsWhat percentage of AIkido Pharma is owned by insiders or institutions?
Currently 0.061% of AIkido Pharma shares are held by insiders and 16.015% by institutions. How many people work for AIkido Pharma?
Latest data suggests 4 work at AIkido Pharma. When does the fiscal year end for AIkido Pharma?
AIkido Pharma's fiscal year ends in December. Where is AIkido Pharma based?
AIkido Pharma's address is: One Rockefeller Plaza, New York, NY, United States, 10020 What is AIkido Pharma's ISIN number?
AIkido Pharma's international securities identification number is: US0088751062 What is AIkido Pharma's CUSIP number?
AIkido Pharma's Committee on Uniform Securities Identification Procedures number is: 008875106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert